Delivery Investors
Delivery is one of the most actively funded categories on CapLink, with 140 verified investors currently backing companies in the space.
The mix is led by VC, PE/Buy-Out and Corporate VC, alongside 2 other investor types. Deal coverage spans Pre-Seed through PE/Buy-out, with the largest concentration at Series A.
Investor headquarters cluster in United States, Canada, United Kingdom, South Africa and Mexico, with activity across 194 countries in total. Ticket sizes range from roughly $10K to $1500M, covering early angel cheques through to growth-stage rounds.
Use the pre-filtered database below to explore every Delivery investor on CapLink, or sign up to unlock contact details, ticket sizes and detailed investment criteria.
Delivery investor database
140 investors matched for Delivery. Sign up to unlock contact details and full profiles.
| Investor |
|---|
DH Ventures (Delivery Hero Ventures) We invest in ambitious founders disrupting the global food and retail ecosystem and adjacent markets. Our areas of specialization include internet (e-commerce, marketplaces, direct to consumer), B2B (digital enablement, food supply chain, retail automation) and fintech (digital payments, financial inclusion). |
![]() IPSA IPSA is a private equity and venture capital firm specializing in seed, startup, early-stage, mid venture, later stage, growth capital, and pre-IPO investments. The firm prefers to invest in life sciences, Internet, telecommunications, biotechnology, medical, energy, chemistry, information and communications technology, water purification, natural resources, cleantech, capital goods, and distribution sectors. In life science sector it further invests in clinical-stage drug development, medical devices, drug delivery, and development services. In information and communications technology sector the firm invests with a focus in content, software, enabling technology, and infrastructure. In natural resources sector it invests further in exploration and production and renewable energy and clean technology. The firm seeks to invest in companies based in European Union with a focus on France, the U.K., Germany, the Netherlands, and Denmark and it also invest occasionally in companies based in North America. It seeks to invest in the first instance between €1 million ($1.33 million) and €5 million ($6.68 million) for a minority stake in the company. It seeks to invest in companies with revenues between €10 million ($13.37 million) and €100 million ($133.73 million). The firm prefers to be the lead or a co-lead investor in its portfolio companies. It seeks to hold a board seat in its portfolio companies. The firm exits from its portfolio companies through an IPO or trade sale within five years. The firm was formerly known as Innoven Partenaires S.A. IPSA was founded in 1997 and is based in Paris, France. |
![]() DocuSign DocuSign, founded in 2003 by Thomas H. Gonser and Court Lorenzini, is a leading provider of cloud-based electronic signature solutions. Headquartered in San Francisco, California, the company has grown to serve over 1 million customers and hundreds of millions of users across more than 180 countries.
DocuSign's platform enables organizations to securely collect information, automate data workflows, and manage agreements, effectively eliminating manual, paper-based processes. The company offers a suite of products, including eSignature, Payments, Identify, Document Generation, Web Forms, Electronic Notarization, Multi-channel Delivery, and APIs, all designed to streamline agreement processes and enhance business efficiency. In addition to its core offerings, DocuSign has expanded into intelligent agreement management, leveraging AI to provide advanced management and insights into business contracts.
This strategic move aims to address the complexities of contract management and improve operational efficiency for businesses. DocuSign's commitment to innovation and customer-centric solutions has solidified its position as a leader in the electronic signature and agreement management industry. |
Parallel Developer and retailer of cannabis-based medical products intended to empower health and well-being. The company offers a wide variety of medical, health and wellness products in multiple delivery options, including vaporizer pens, tinctures, oral sprays, topical creams and soft gels, enabling customers to naturally regulate and improve everything from mood to stress and pain levels. |
inCapital inCapital is a private equity and venture capital firm specializing in direct and fund of fund investments. Within direct investments, it makes turnaround, emerging growth, seed/startup, early, mid venture, recapitalization, buyout, and growth capital investments. Within fund of fund investments, it invests in private equity funds. The firm seeks to invest in the internet retail, multiline retail, consumer finance, food products, television advertising, ground postal and courier delivery services, software and services, and pharmaceutical sector. It invests in Uruguay. It typically invests between $5 million and $20 million in companies with annual value between $5 million to $10 million, enterprise value between $10 million and $100 million, and EBITDA between $0.5 million and $20 million. The firms makes balance sheet investments and also invests through its personal capital. inCapital was founded in 2012 and is based in Montevideo, Uruguay. |
LRVHealth LRVHealth is a healthcare venture capital platform that has been partnering with disruptive founders as their first institutional investors since 2000. They have a history of building transformational healthcare companies, including GetWellNetwork, Phreesia, Intelycare, Medventive (Change Healthcare), Diameter Health, and Verata (Olive). Their approach focuses on connecting the largest strategic network of leading healthcare organizations with entrepreneurs addressing the industry's biggest challenges and opportunities.
LRVHealth's value proposition includes unparalleled expertise in the intricacies of the U.S. healthcare system and a willingness to serve as both thought and action partners. They offer unique and strategic insights to help scale efforts across various healthcare delivery models and demonstrate enthusiasm to collaborate in establishing new standards of care.
Their portfolio companies have praised their support in refining business models, understanding the payer and provider landscape, and opening doors to the right partners. LRVHealth's commitment to innovation and deep industry expertise aligns with their mission to transform healthcare from the inside. |
Samaipata Samaipata is an early-stage founders’ fund investing in tech companies with network effects across Europe and beyond. The fund was founded in 2016 by two entrepreneurs, José del Barrio and Eduardo Díez-Hochleitner. José was the co-founder and CEO of the leading food-delivery platform in Spain (La Nevera Roja) which was sold for $100 million. Eduardo was founder of a 3D sound system sold to Dolby (IMM Sound), former Partner at Apax Partners, a prolific business angel, and the current Chairman at MásMóvil, recently valued at €20 billion, becoming the first Southern European Decacorn. |
![]() Bon Angels Co-Founded by BG Chang,Simon Kang and Inae Song in 2006 as an angel investment team, built up a corporate body in 2010, BonAngels Venture Partners is arguably the first early-stage venture capital of significance in Korea.
We have contributed to form the foundation of Korean startup ecosystem over the past 10 years. BonAngels have invested in more than 120 startups in the fields of IT/Tech (mobile, SW, game), as well as O2O, Education, Fintech and etc. We’ve invested in companies like `Woowahan’, a leading and dominantly used food delivery service app in Korea, ‘Daily’ pioneer of hotel reservation app and ‘Jobplanet’ famously known as Korean ‘Glassdoor’ service. We have our expertise in IT, but are interested in startup teams that push the edge of what’s possible in every industry. |
Founderful Welcome to Founderful; make yourself at home. First up, some introductions. We're a venture capital firm based in Switzerland. We've been founders ourselves, and our experiences shape the way we invest. We lead with an understanding of founders, offering companionship and support as the first investor. We back founder teams as their lead investor in their first financing round; first, fast, and founder-friendly. We have the courage to invest early, when it matters the most, giving our founders the support they need to get started and convince people of their big ambitions. Take the next step with those who've been in your shoes. Whether it's strategic or operational, our team - built from experienced entrepreneurs and operators in finance, legal, people and culture, marketing, and branding - is here to answer all your questions and more. Get access to our community of investors, made up of the top entrepreneurs from the Swiss and wider European ecosystem. This includes the founders of Duolingo, Climeworks, Scandit, Delivery Hero, Proton, and many other category-defining technology companies. |
![]() HV Capital We believe the best way to tackle complexity is an open mindset. In our team software specialists meet marketing experts, former entrepreneurs meet distinguished financiers and experienced professionals meet young talent. We are a team of 41 experts, with different educational backgrounds, different nationalities and different interests.Yes
Since 2000, HV Capital, formerly HV Holtzbrinck Ventures, has backed Internet and technology companies through various generations of funds and is one of the most successful and financially strongest early-stage and growth venture capitalist in Europe. HV’s funds have already invested in around 200 companies, including Zalando, Delivery Hero, FlixBus and SumUp. The total of all HV‘s funds amounts to €1.7 billion. The company supports startups with capital between €500,000 and €50 million. This makes HV Capital one of the few venture capitalists in Europe that can back startups through all growth phases. |
![]() Investcorp Founded in 1982, we’ve built a global reputation for superior performance, innovation and client service.Investcorp has earned distinction through reliability, transparency, business judgment, value creation, innovation and superior results.We combine the growth dynamics of Gulf capital and the alternative investment industry with international management discipline.We were founded as, and remain, a firm that is global in its outlook, attitude and culture. As such, we have offices in New York, London, Bahrain, Abu Dhabi, Doha, Riyadh and Singapore.As one of the largest and most diverse alternative investment managers – in terms of both product and geography – we are uniquely placed to offer our clients a range of attractive investment products.We currently have more than $22.2 billion of assets under management.We have a unique placement capability in the Gulf, where we offer a high level of personal service to an investor base of high-net-worth individuals and institutions.We are different because we offer investments to our clients on a deal-by-deal basis, reflecting our investors' preference for investment discretion.What's more, we co-invest significantly with our clients across our business areas, which ensures that our interests are firmly aligned with theirs. Many of our clients have also chosen to be shareholders of Investcorp; they feel pride and involvement in, and ownership of, our success.At Investcorp, we pride ourselves on the long-term relationships we have built with our clients, based on mutual trust, respect and delivery. Our dedicated client service team acts as a trusted and informed advisor to clients. |
![]() Point Nine Point Nine Capital is an early-stage venture capital firm specializing in SaaS, AI, and B2B marketplaces. Founded in 2008 and headquartered in Berlin, Germany, the firm focuses on seed-stage investments, with initial ticket sizes ranging from €0.5 to €5 million. While Europe is their primary market, they also invest in the U.S., Canada, and other countries, maintaining a geo-agnostic approach.
Notable portfolio companies include Algolia, Chainalysis, Contentful, Delivery Hero, Docplanner, Loom, and Zendesk. The firm has a track record of over 65% of their backed companies progressing to raise a Series A round. |
RTP Global We specialize in early-stage startup investments, operating in sectors such as artificial intelligence, food technology, e-commerce, transportation, and fintech. We have invested in 90 companies founded in more than 10 countries, including the USA, Europe, India, and South-East Asia. Five of our early-stage investments have grown into multi-billion dollar public companies: Yandex, EPAM, Delivery Hero, RingCentral, and Datadog. Our offices are located in New York, London, and Bangalore. We have built our flexible approach and fast-paced decision making team around the needs of business founders because we understand what it takes to create market disruption. We know that exponential growth is possible when the right investor is matched with the right founder around the right idea. We admire founders who are ready for the short term sprints, the long term marathons and are prepared to work hard to be successful. We bring people power to your business. |
![]() Emergo Ltd. Emergo Ltd. is a private equity and venture capital firm specializing in startups, early stage and mature investments. The firm invests in biotechnology, construction, engineering and data service solutions, data design capture, integration, conversion, management, maintenance and delivery, oil and gas exploration and development, oil and gas services, management services, project management and implementation, health care, medical devices, pharmaceuticals, nutraceuticals, real estate, manufacturing, retailing, financial services, biomedical research and development, and technology sectors. It prefers to invest in companies based in North America and Europe. It invests up to $1 million in a company. The firm provides both debt and equity financing. It also provides advisory services, securitization services, and guaranteeing of loans. Emergo Ltd. was founded in 1990 and is based in Nicosia, Cyprus with additional offices in Geneva, Switzerland and Calgary, Canada. |
Lux Capital Lux Capital Management, LLC is a venture capital firm specializing in investments in series B, seed, early stage investments, special situations, and corporate spinouts. The firm primarily invests in energy, life sciences, biopharmaceutical, healthcare, and technology. It also seeks to invest in emerging technologies with a focus on digital health, advanced materials, drug delivery, therapeutics, mobile health, services, novel materials, energy, energy technology, wireless, semiconductors, nanotechnology, alternative energy technologies, and biotechnology sectors. The firm seeks to invest in deep technology such as machine learning, artificial intelligence, 3D printing, meta materials, robotics, and solid-state electronics. It also invests in augmented reality for the blind, neuro stimulation, age extending blood transplants, synthetic biology for industrial production, and Internet of things security for industrial and factory automation. The firm targets investing from $0.10 million and $100 million in a startup. The firm seeks to be a first institutional investor in its portfolio companies. It also provides follow on funding for future financing rounds. Lux Capital Management, LLC was founded in 2000 and is headquartered in New York, New York with an additional office in Menlo Park, California and San Diego, California. |
![]() NFQ Capital NFQ accelerates the success of entrepreneurs with a current team of 300 specialists delivering company-building services including strategy, engineering, operational scaling, recruiting, business development, product delivery, and product marketing. With more than 10 years of experience in eCommerce and Travel we provide technology excellence.NFQ invests – we see ourselves as the “Entrepreneurs Behind the Entrepreneurs” and we take a very hands-on approach to investing. We strongly believe that the key to successful investing lies not just in finding the next outstanding internet brand – but in helping to create it. We focus on later-stage growth phases but do also seed and incubation stages.NFQ has offices in Europe, Southeast Asia and San Francisco. |
OneVentures OneVentures is a leading Australian venture capital firm specializing in scaling technology and healthcare companies through growth equity and credit investments. With over $900 million in funds under management, the firm focuses on later-stage investments, providing both capital and strategic support to accelerate the growth of its portfolio companies. Their investment strategy targets high-quality scale-up technology businesses, particularly those requiring support with corporate restructuring, offshore market entry, and expertise to accelerate their next phase of growth.
OneVentures' portfolio includes innovative companies such as Vaxxas, which specializes in needle-free vaccine delivery technology; Employment Hero, a cloud-based human resources software provider; Phocas, a data and business intelligence software company; Buildkite, a platform for automating development processes; BiVACOR, which is developing a total artificial heart to replace a failing heart; and Fleet Space Technologies, known for its advanced nanosatellite technology. |
![]() ORI Capital ORI Capital is a venture capital firm specializing in seed, early stage to Series B, and late stage investments. It seeks to invests in innovative companies with disruptive technologies in the healthcare industry. The firm invests in the field of therapeutics, drug delivery, and diagnostics that address diseases with high mortality rates such as cancers, neurodegenerative and metabolic diseases, as well as rare diseases caused by genetic mutation. It seeks to invest globally. The firm prefers to exit its investment through M&A. ORI Capital was founded in 2015 and is based in Wanchai, Hong Kong. |
![]() Altaris, LLC Altaris, LLC is a private equity firm specializing in corporate carve outs and partnerships, acquisitions, debt financing, private equity / buyouts fund, venture capital fund, recapitalization, divestitures, strategic co-ownership arrangements, leverage buyouts, PIPES, middle market, industry consolidation and growth capital investments. It prefers to invest in pharmaceuticals, therapeutics, contract development and manufacturing, drug delivery technologies, medical devices, outsourced design and manufacturing, supply chain, minimally invasive technologies, life sciences and diagnostics, bioprocessing, advanced imaging & precision medicine, R&D efficiency, healthcare services, technology-enabled services, digitization of processes, and preventative care and wellness sectors. The firm prefers to invests in companies in the United States, Canada, North America and Western Europe. It prefers to invest in equity investment between $50 million and $500 million. It makes control, majority, and significant minority investments. Altaris, LLC was founded in 2003 and is based in New York, New York. |
ArchiMed SAS ArchiMed SAS is a private equity and venture capital firm specializing investing in small and middle market, growth buyouts, acquisitions, small-cap and mid-cap companies. The firm seeks to invest in healthcare industries with focus on biopharmaceutical products & services, life science tools, biologic services, medical devices & technologies, diagnostics, healthcare IT and consumer health. In Biopharma firm prefers to invest in small and large molecules, APIs, generic, primary and specialty pharma, pharma delivery, veterinary, outsourcing services such as bioanalytical, drug discovery or formulation services, Consumer Health, In Vitro Diagnostics, CRO, CDMO, CLO or specialized consulting, in Healthcare IT firm prefers to invest in clinical or non-clinical solutions for care providers, care payer solutions, biopharma-related software, outsourcing services. In care provider firm prefers to invest in homecare, specialized care delivery, outsourcing services, in Medtech firm provider, the firm prefers to invest in implants, equipment, consumables, services, outsourcing in field such as cardiovascular, dental, drug delivery, infection control, neuro, ophtalmo, orthopaedics, general surgery, wound care, veterinary, in public safety firm prefers to invest in biocontrol, food safety, environmental and healthcare-related TIC, health at work, in Diagnostics it prefers to invest in including In Vitro (IVD) and Imaging, in Life Sciences the firm prefers to invest in including tools, equipment, consumables and services, whether for bioprocessing, research, in consumer health it prefers to invest in cosmetics, health supplements, aesthetics, wellness, selfcare and physio. It prefers to invest in Europe, France, Switzerland, North America, APAC and LATAM region. It prefers to invest between €5 million ($5.36 million) and €1,000 million ($1,100 million) in the companies with sales value between $6.22 million and $124.33 million. It prefers to take majority and minority stake in the companies. ArchiMed SAS was founded in 2014 and is based in Lyon, France with additional offices in Paris, France; New York, New York; Singapore, Singapore and Tokyo, Japan. |
Granite Asia Granite Asia, also formerly known as GGV Capital, LLC is a private equity and venture capital firm specializing in equity and credit solutions, growth capital, expansion stage companies, bridge financing, PIPIEs, early and late-stage opportunities, seed and early series A and B to growth capital, and cross-border business models investments. It invests across a range of sectors including finance solutions, technology, telecom, media, social internet, smart tech, information technology, services and healthcare, mobile technology, financial technology, frontier tech, internet, connected devices, social, commerce, travel, digital media, digital models, games, new retail, music, marketing and advertising, cloud based software delivery, enterprise workflow, supply chain solutions, food systems & sustainability, energy transition and automation, SaaS, security, healthcare innovation and wellness, artificial intelligence, infrastructure, CRO research, biology, e-commerce, networking and computing, software and services, clean technology, workmanship, materials, new equipment, advanced manufacturing, wireless internet, consumer electronics, home furnishings, homebuilding, household appliances, housewares and specialties, leisure products, textiles, apparels, and luxury goods, consumer digital lending, commercial digital lending, finanicial software, consumer growth and transformation sectors. The firm primarily invests in companies based in Asia and the APAC region including Southeast Asia, Europe, Israel, USA, Latin America, Japan, China, India, and Australia. It seeks to make initial investment between $5 million and $25 million, with significant capacity for follow-on investments. The firm prefers to be a lead investor and seeks to take a board seat in its portfolio companies. Granite Asia was founded in 2000 and is based in Singapore with additional offices in Menlo Park, California; Beijing, China; and Shanghai, China. |
HO2 Partners HO2 Partners is no longer investing. It is a venture capital firm specializing in seed and early stage investments. The firm prefers to invest in supply chain management software, wireless infrastructure, telecommunications enterprise management, and enterprise digital media delivery. It primarily invests in companies headquartered in Texas with focus on Dallas-Fort Worth. The firm invests in companies with enterprise value of $200 million or more in three to five years. It participates in follow-on rounds of its most successful portfolio companies with the objective of owning an equity stake between 10 percent and 15 percent at exit. It seeks to take a seat on the board of directors and acts as the lead or co-lead investor. HO2 Partners was founded in 1998 and is based in Dallas, Texas. |
![]() iSELECT FUND iSelect Fund is a venture capital firm dedicated to investing at the intersection of agriculture and human health. The firm focuses on agtech, soil, and crop health solutions to meet the growing global demand for protein, enhance the taste, nutrition, and affordability of food, improve farmer profitability, and promote environmental sustainability. In the healthcare sector, iSelect Fund invests in data analysis and delivery technologies that facilitate early detection, intervention, prevention, and treatment of cardio-metabolic diseases.
The firm's investment thesis, "Food is Health," underscores the direct impact of nutrition on health outcomes, aiming to reduce the cost of good nutrition, increase access, and improve longevity. iSelect Fund employs a balanced portfolio approach, utilizing diversification and maximizing optionality to manage |
RTP Ventures RTP Ventures, also known as RTP Global, is a venture capital firm founded by Leonid Boguslavsky in 2011. The firm focuses on early-stage investments in technology companies across various sectors, including Big Data, SaaS, cloud computing, Fintech, Health Care, IoT, and Information Security. RTP Ventures has a global presence with offices in New York, London, Paris, Bangalore, and Dubai.
Notable investments include Datadog, Delivery Hero, and RingCentral. |
![]() SCP Vitalife Vitalife Partners is a venture capital investment firm specializing in early stage and mid stage investments. The firm prefers to invest in the life science, medical devices for therapeutic uses, novel diagnostic methods, biomaterials, specialty pharmaceuticals and drug delivery, and healthcare services sector. It invests in companies based in the United States and Israel region. The firm seeks to invest between $0.5 million and $7 million in companies, with a typical total investment of $7 million to $15 million over the lifespan of the investment. Vitalife Partners was founded in 2002 and is based in Malvern, Pennsylvania with additional offices in Wayne, Pennsylvania; and Tel-Aviv, Israel. |
Understanding Delivery investors
What are Delivery investors, and what do they look for?
Delivery economics are decided at the level of a single order, and investors go straight there. Revenue per order against the fully loaded cost of fulfilling it, including courier payment, vehicle or equipment cost, support, refunds and the share of fixed operational overhead. Companies that present growth in orders without contribution margin per order are describing scale rather than progress, and investors in this category learned that distinction expensively. Density is the second determinant. Delivery costs fall sharply when orders cluster geographically, because couriers complete more drops per hour, so a business dominant in a few areas is structurally healthier than one spread thinly across a city. Investors examine orders per square kilometre and per courier hour rather than aggregate volume. Labour arrangements form the third axis and carry real risk in Europe. Courts and regulators across several countries have reclassified delivery workers as employees rather than contractors, with substantial retroactive cost. Investors will ask how your workforce is engaged, what exposure exists, and whether the model survives reclassification.
Why Delivery is attracting investor interest
The category consolidated hard, and what survived is a narrower and better-understood proposition. A period of heavy subsidy produced rapid growth and enormous losses, and when funding tightened many operators exited or merged. Investors emerging from that are focused on unit economics and density rather than on market share, and they are sceptical of growth that arrives through discounting. Grocery and pharmacy delivery proved more durable than restaurant delivery in several European markets, because basket sizes are larger and order frequency is more predictable, which improves the economics per drop considerably. The infrastructure layer attracted separate and steadier interest. Routing software, courier management, dark store operations and last-mile logistics tooling sell to operators rather than competing with them, and they carry software economics without the labour exposure. Regulatory attention has become a defining feature. European rules on platform work, algorithmic management and worker classification are tightening, which raises costs for operators and simultaneously creates demand for compliance and workforce management tooling.
Which funding stages Delivery investors are active at
This is a capital-intensive category and investors now approach it accordingly. Seed rounds fund launching in a single area and proving that orders can be fulfilled at a sustainable cost. Investors want density in one location rather than presence in several, since thin coverage demonstrates nothing about the model. Series A requires positive contribution margin per order in at least one mature market, without subsidy. This is the decisive gate, and the sector's recent history means investors test it thoroughly, including by examining what happens to volume when promotions are withdrawn. Series B funds replication into new areas, and investors assess whether each new market reaches profitability faster than the last. A replication curve that is not improving indicates that the playbook depends on spending rather than on operational learning. Later-stage capital for European delivery operators has become scarce, and consolidation is the dominant outcome. Software and infrastructure businesses serving the sector have an easier funding path and attract conventional enterprise software investors.
Types of investors active in Delivery
Investors who read density metrics, courier utilisation and contribution margin per order fluently. They are unsentimental about subsidised growth and their operational advice on city launch sequencing is specific and hard-won.
Corporate investors from supermarket and pharmacy groups seeking delivery capability. They bring order volume and product supply, which addresses the demand side directly, and they are frequent acquirers of operators serving their categories.
Investors from freight, postal and mobility operators with fleet capability and routing expertise. They evaluate against operational efficiency rather than consumer growth and can absorb delivery operations into existing networks.
Funds backing the tooling layer rather than the operators, including routing, workforce management and dark store software. They avoid labour exposure entirely and apply conventional software metrics, which makes this the easier funding path.
Providers funding vehicles, equipment and the cash cycle of operations. Structurally necessary for asset-heavy models, and arranging it early prevents equity being consumed by things a lender would readily finance.
Ready to reach Delivery investors?
Create a free CapLink account to unlock full investor profiles, contact details, ticket sizes and intelligent matching.













